We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

13th May 2020
Selected Chemistry & Industry magazine issue

Select an Issue


C&I e-books

C&I e-books

C&I apps

iOS App
Android App

Computing clean energy Computing clean energy

High performance computing is supercharging research into clean energy solutions.

Read the feature article


Delhi smog

Air quality boost for India

A. Nair , May 2020

Air pollution kills 1.25m people in India every year. India’s capital New Delhi has the worst air pollution of any capital city. However, air pollution has dropped dramatically as a result of lockdown to control coronavirus.


Hydrogen fuel cell

Hydrogen economy

Maria Burke, May 2020

As the world looks for ways to keep global warming in check, hydrogen is in the spotlight as a green energy option. Maria Burke explores whether hydrogen’s time has come


Against all odds

Marelene Rayner-Canham and Geoff Rayner-Canham, May 2020

Since the dawn of the 20th century, there has been a huge change in the career opportunities available to women. Although still generally outnumbered by men, it is an everyday experience to learn of female doctors, lawyers, politicians, academics, architects, priests, engineers, scientists etc.


Business digest

May 2020

US-headquartered gene therapy company Asklepios BioPharmaceutical has acquired Paris-based gene therapy company BrainVectis, a spin out from the French National Institute for Health and Medical Research.


Movers & Shakers

May 2020

Lisa von Moltke, former acting senior VP and head of clinical development at US global biotechnology company Alkermes, has moved to Seres Therapeutics as CMO. The Boston-headquartered biotechnology company Seres focuses on drugs to treat infectious, metabolic, and inflammatory diseases by targeting the underlying biology of the human microbiome.

C&I Click to view our flipbook